About LASSEN THERAPEUTICS, INC.
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases, with a focus on targeting interleukin-11, a cytokine central to fibrosis.
Developing novel biotherapeuticsApplying industry-leading antibody technologiesBuilding robust antibody development platforms and pipelinesConducting preclinical and clinical trials (e.g., Phase 1 and Phase 2 studies)Collaborating with academic and industry partners
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to LASSEN THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.